The Anti-Inflammatory Effects of Glucagon-Like Peptide Receptor Agonist Lixisenatide on the Retinal Nuclear and Nerve Fiber Layers in an Animal Model of Early Type 2 Diabetes

May 04, 2020 | Histopathology

For the latest news in the Histopathology industry, you can always count on Lab.Equipment as we publish articles from trusted online sources on a daily basis. Read this entry acquired from The American Journal of Pathology:

This study explored the anti-inflammatory effects of a glucagon-like peptide-1 receptor agonist (GLP-1RA), known as lixisenatide, on the eyes of early type 2 diabetic mice. Diabetic (db/db) mice were divided into three groups: GLP-1RA [lixisenatide (LIX)], insulin (INS) with controlled hyperglycemia based on the glucose concentration of lixisenatide, and diabetic control (D-CON). Nondiabetic control mice (db/dm) were also characterized for comparison. After 8 weeks of treatment, mRNA levels of inflammatory markers, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling, immunohistochemical staining; Western blot of glial fibrillary acidic protein (GFAP) and thioredoxin-interacting protein; and retinal thickness were assessed in the central and peripheral neurosensory retina.... Want to read more? Visit the The American Journal of Pathology​ Blog.

If you're in the Pathology industry and are looking for premium Histopathology equipment for your basic or advanced applications, then you have come to the right place. Lab.Equipment supplies a range of products for labs running histophatological tests. Shop our recommended Histopathology laboratory equipment including:

Find user-friendly equipment for your application by shopping our inventory of products from popular MFGs such as:

Dealing with other scientific or industrial applications? No worries. We got you covered. Browse our range of robust lab equipment for food testing, environmental, chemistry applications and more.

Back To Top
We are fully compliant with the GDPR laws. We promise to safeguard your data and protect your privacy rights.